Technical Data
L2601-10M
Lipoprotein, Low Density, Oxidized, Human (LDL)
2mg
Molecular Biology Storage: 4C Do Not FreezeShipping: Blue Ice
Low density lipoprotein (LDL) oxidative modification is one of the major processes involved in atherosclerosis along with other degenerative disorders. Oxidised LDL is preferentially accumulated by macrophages which become so called "foam cells" within the atheromatous plaque and contributes to the accumulation of cholesterol, typical of atherosclerosis.

Applications:
Suitable for use in Functional Assays. Other applications not tested.

Recommended Dilutions:
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4C. Do not freeze. Aliquots are stable for 4 weeks. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Source: Human plasma
Purity: Purified to homogeneity by ultra-centrifugation. Oxidized using 20uM cupric sulphate in PBS at 37C for 24 hours. Oxidation is terminated with excess EDTA. The level of oxidation is measured using TBARS (Thiobarbituric acid reactive substances) determination using a Malondialdehyde (MDA) standard.
Concentration: ~2mg/ml
Form: Supplied as a liquid in PBS, 0.3 mM EDTA

Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.